Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Biogen and Eisai trial drug in asymptomatic Alzheimer’s disease
Pharmaforum
Tue, 07/14/20 - 10:31 am
Tags:
Biogen, Eisai, Alzheimer's disease, amyloid, BAN2401, clinical trials
Biogen Shares Positive Data on Phase I/II Trial of Tofersen for SOD1-ALS
BioSpace
Sat, 07/11/20 - 11:45 am
Tags:
Biogen, ALS, tofersen, BIIB067, clinical trials
Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed
BioSpace
Thu, 07/9/20 - 10:27 pm
Tags:
Alzheimer's disease, drug development, diagnostics, aducanumab, Biogen
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing
Xconomy
Thu, 07/9/20 - 12:12 am
Tags:
Biogen, FDA, aducanumab, Alzheimer's disease
AstraZeneca, Lilly, Sanofi and others raise prices to start July: report
Fierce Pharma
Wed, 07/8/20 - 10:54 am
Tags:
AstraZeneca, Eli Lilly, Sanofi, drug pricing, GSK, Biogen
Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease
Fierce Biotech
Mon, 07/6/20 - 12:00 pm
Tags:
Biogen, gene therapy, eye disease, Harvard
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Mon, 06/22/20 - 08:36 pm
Tags:
Biogen, Tecfidera, Mylan, patents, generics, MS, multiple sclerosis
Third-quarter events to watch for large drug makers
EP Vantage
Mon, 06/22/20 - 10:35 am
Tags:
Biogen, aducanumab, Sanofi, THOR-707, Bristol-Myers Squibb, pegbelfermin, Eli Lilly, FDA
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Fierce Pharma
Thu, 06/18/20 - 10:44 am
Tags:
Biogen, Mylan, Tecfidera, patents, MS, multiple sclerosis
Biogen trades lab coats for laptops with virtual summer STEM program for high schoolers
Fierce Pharma
Wed, 06/10/20 - 11:49 pm
Tags:
Biogen, STEM, COVID-19, pandemic, community service
Biogen’s Spinraza Shows Sustained Benefit for Pre-Symptomatic SMA Patients
BioSpace
Wed, 06/10/20 - 11:46 pm
Tags:
Biogen, SMA, Spinraza, clinical trials
Biogen gears up Swiss manufacturing facility for potential aducanumab rollout
Fierce Pharma
Thu, 05/7/20 - 10:17 pm
Tags:
Biogen, Alzheimer's disease, aducanumab, FDA, drug manufacturing
Has Biogen Found the Answer to Treating Alzheimer's?
Motley Fool
Fri, 05/1/20 - 11:07 am
Tags:
Biogen, FDA, Alzheimer's disease, aducanumab
Roche shares SMA data ahead of scrap with Biogen, Novartis
Fierce Biotech
Tue, 04/28/20 - 10:59 am
Tags:
Roche, Biogen, Novartis, SMA, spinal muscular atrophy, risdiplam, clinical trials
Biogen shares fall as company pushes back Alzheimer’s drug filing
MedCity News
Wed, 04/22/20 - 11:11 am
Tags:
Biogen, earnings, Alzheimer's disease, aducanumab, FDA
Thanks to Spinraza and biosims—if not aducanumb—Biogen CEO Vounatsos scored $18M+ in 2019 pay
Fierce Pharma
Tue, 04/21/20 - 12:15 pm
Tags:
Biogen, Pharma CEOs, Michel Vounatsos, executive pay
After 'superspreader' meeting, recovered Biogen employees give blood to aid coronavirus research
Fierce Pharma
Fri, 04/17/20 - 11:28 pm
Tags:
Biogen, COVID-19, pandemic, biobank
Biogen Is Building a COVID-19 Biobank With the Broad Institute
Motley Fool
Fri, 04/17/20 - 10:37 am
Tags:
Biogen, Broad Institute, biobank, COVID-19, pandemic
Biogen Alzheimer's filing likely hit by pandemic, as drugs against the disease set for delay
Fierce Biotech
Tue, 04/14/20 - 10:06 am
Tags:
Biogen, Alzheimer's disease, aducanumab, FDA, pandemic, COVID-19
Biogen Sues Company Over Allegedly Selling Knockoff Alzheimer's Treatment
BioSpace
Sat, 04/11/20 - 10:59 pm
Tags:
Biogen, patents, Alzheimer's disease, aducanumab, Creative Biolabs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.